Medicare Coverage for New Blood Tests to Screen for Colorectal Cancer.
This bill expands the Medicare program to cover FDA-approved blood-based tests for the early detection of colorectal cancer. The goal is to boost screening rates, particularly in underserved communities, by offering a less invasive alternative to traditional methods. Medicare beneficiaries will gain easier access to crucial preventative screening.
Key points
Medicare will now cover the cost of new, approved blood tests for colorectal cancer screening.
The change aims to increase participation in screening, especially among communities of color and following pandemic-related declines.
Specific time limits are set for how often beneficiaries can receive the new blood tests, fecal tests, and colonoscopies under coverage.
Expired
Citizen Poll